Trending: Johnson & Johnson 1Q Adjust Earnings Beat Forecasts as Company Raises Dividend

09:51 ET -- Johnson & Johnson is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The healthcare company reported higher first-quarter sales Tuesday, which climbed 2.3% to $21.38 billion, slightly lower than the $21.39 billion forecast by analysts polled by FactSet. JNJ saw a net profit of $5.35 billion, or $2.20 a share, compared with a loss of $491 million, or 19 cents a share, for the same period a year earlier. Its adjusted earnings per share were $2.71, beating analysts' expectations of $2.64, according to FactSet. JNJ now sees full-year adjusted earnings per share of $10.57 to $10.72, compared with its prior forecast of $10.55 to $10.75. The company's board, meanwhile, raised its quarterly dividend 4.2% to $1.24. Dow Jones & Co. owns Factiva. (susan.solan@wsj.com)

(END) Dow Jones Newswires

April 16, 2024 10:06 ET (14:06 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.